Bexxar® (tositumomab and iodine I 131 tositumomab) is well tolerated and efficacious in heavily pretreated patients with non-Hodgkin's lymphoma (NHL) and mild thrombocytopenia Meeting Abstract
| Authors: | Goldsmith, S. J.; Kostakoglu, L.; Wahl, R.; Alavi, A.; Divgi, C.; Hankins, J.; Zelenetz, A.; Kaminski, M. |
| Abstract Title: | Bexxar® (tositumomab and iodine I 131 tositumomab) is well tolerated and efficacious in heavily pretreated patients with non-Hodgkin's lymphoma (NHL) and mild thrombocytopenia |
| Meeting Title: | 50th Annual Meeting of the Society of Nuclear Medicine (SNM) |
| Journal Title: | Journal of Nuclear Medicine |
| Volume: | 44 |
| Issue: | 5 Suppl. |
| Meeting Dates: | 2003 Jun 21-25 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0161-5505 |
| Publisher: | Society of Nuclear Medicine |
| Date Published: | 2003-05-01 |
| Start Page: | 33P |
| End Page: | 34P |
| Language: | English |
| ACCESSION: | WOS:000182729600106 |
| PROVIDER: | wos |
| PUBMED: | 12757004 |
| Notes: | Meeting Abstract: 105 -- 50th Annual Meeting of the Society-of-Nuclear-Medicine -- JUN 21-25, 2003 -- NEW ORLEANS, LOUISIANA -- S -- Source: Wos |
Citation Impact
Related MSK Work